Table 2.
STEMI | P-Value | NSTEMI | P-Value | |||||||
---|---|---|---|---|---|---|---|---|---|---|
Complication | Total (n = 501) | 1999/01 (n =209) | 2003/05 (n = 162) | 2007/09 (n = 130) | Total (n = 454) | 1999/01 (n = 137) | 2003/05 (n = 141) | 2007/09 (n = 176) | ||
Atrial fibrillation | 26 (5.2%) | 12(5.7%) | 9 (5.6%) | 5 (3.9%) | 0.26 | 15 (3.3%) | 7 (5.1%) | 6 (4.3%) | 2 (1.1%) | 0.24 |
Heart failure | 85 (17.0%) | 42 (20.1%) | 14 (8.6%) | 29 (22.3%) | 0.28 | 51 (11.2%) | 20 (14.6%) | 17 (12.1%) | 14(8.0%) | 0.20 |
Cardiogenic shock | 23 (4.6%) | 12 (5.7%) | 2 (1.2%) | 9 (6.9%) | 0.18 | 7 (1.5%) | 5 (3.7%) | 2 (1.4%) | 0 | 0.18 |
Death | 17 (3.4%) | 6 (2.9%) | 4 (2.5%) | 7 (5.4%) | 0.22 | 12 (2.6%) | 5 (3.7%) | 5 (3.6%) | 2 (1.1%) | 0.11 |
Length of Stay (median; days) | 3.0 | 4.0 | 3.0 | 3.0 | 0.27 | 3.0 | 3.0 | 3.0 | 3.0 | 0.88 |